Simulation-Based Education for Physicians to Increase Oral Anticoagulants in Hospitalized Elderly Patients with Atrial Fibrillation.
Administration, Oral
Aged
Aged, 80 and over
Anticoagulants
/ administration & dosage
Atrial Fibrillation
/ drug therapy
Clinical Competence
/ standards
Cluster Analysis
Education, Medical, Continuing
/ methods
Female
Geriatrics
/ education
Humans
Male
Odds Ratio
Patient Simulation
Simulation Training
/ methods
Stroke
/ drug therapy
Atrial fibrillation
Cluster randomized trial
Internal medicine and geriatric wards
Older people
Oral anticoagulants
SIM-AF trial
Simulation-based education
Journal
The American journal of medicine
ISSN: 1555-7162
Titre abrégé: Am J Med
Pays: United States
ID NLM: 0267200
Informations de publication
Date de publication:
08 2019
08 2019
Historique:
received:
20
11
2018
revised:
14
03
2019
accepted:
26
03
2019
pubmed:
11
5
2019
medline:
30
1
2020
entrez:
11
5
2019
Statut:
ppublish
Résumé
This study was intended to determine whether a simulation-based education addressed to physicians was able to increase the proportion of hospitalized elderly with atrial fibrillation prescribed with oral anticoagulants (OACs) compared with the usual practice. We conducted a cluster randomized trial (from April 2015 to September 2018) on 32 Italian internal medicine and geriatric wards randomized 1:1 to intervention or control arms. The physicians of wards randomized to intervention received a computer-based e-learning tool with clinical scenarios (Dr Sim), and those of wards randomized to control received no formal educational intervention. The primary outcome was the OAC prescription rate at hospital discharge in the intervention and control arms. Of 452 patients scrutinized, 247 were included in the analysis. Of them, 186 (75.3%) were prescribed with OACs at hospital discharge. No difference was found between the intervention and control arms in the post-intervention phase (odds ratio, 1.46; 95% confidence interval [CI], 0.81-2.64). The differences from the pre- to post-intervention phases in the proportions of patients prescribed with OACs (15.1%; 95% CI, 0%-31.5%) and with direct oral anticoagulants (DOACs) (20%; 95% CI, 0%-39.8%) increased more in the intervention than in the control arm. This simulation-based course did not succeed in increasing the rate of elderly patients prescribed with OACs at hospital discharge compared with the usual practice. Notwithstanding, over time there was a greater increase in the intervention than in the control arm in the proportion of patients prescribed with OACs and DOACs. ClinicalTrials.gov identifier: NCT03188211.
Identifiants
pubmed: 31075225
pii: S0002-9343(19)30382-1
doi: 10.1016/j.amjmed.2019.03.052
pii:
doi:
Substances chimiques
Anticoagulants
0
Banques de données
ClinicalTrials.gov
['NCT03188211']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e634-e647Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.